Bio-Rad Laboratories (BIO) Revenue Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bio-Rad Laboratories | 8.23 Bn | 6.66 Bn | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.02% |
| Dec 31, 2025 | -2.58% |
| Sep 30, 2025 | 0.18% |
| Jun 30, 2025 | 3.95% |
| Mar 31, 2025 | 0.48% |
| Dec 31, 2024 | 1.34% |
| Sep 30, 2024 | 2.99% |
| Jun 30, 2024 | 2.20% |
| Mar 31, 2024 | 1.97% |
| Dec 31, 2023 | 2.00% |
| Sep 30, 2023 | 3.01% |
| Jun 30, 2023 | 3.41% |
| Mar 31, 2023 | 4.18% |
| Dec 31, 2022 | 3.29% |
| Sep 30, 2022 | 4.97% |
| Jun 30, 2022 | 6.49% |
| Mar 31, 2022 | 6.96% |
| Dec 31, 2021 | 5.10% |
| Sep 30, 2021 | 7.99% |
| Jun 30, 2021 | 6.73% |
| Mar 31, 2021 | 9.05% |
| Dec 31, 2020 | 6.72% |
| Sep 30, 2020 | 6.61% |
| Jun 30, 2020 | 1.19% |
| Mar 31, 2020 | 3.87% |
| Dec 31, 2019 | 0.86% |
| Sep 30, 2019 | 1.11% |
| Jun 30, 2019 | 1.30% |
| Mar 31, 2019 | 1.70% |
| Dec 31, 2018 | 0.47% |
| Sep 30, 2018 | 1.54% |
| Jun 30, 2018 | 1.86% |
| Mar 31, 2018 | 1.99% |
| Sep 30, 2017 | 1.38% |
| Jun 30, 2017 | -0.22% |
| Mar 31, 2017 | 0.56% |
| Dec 31, 2016 | 0.76% |
| Sep 30, 2016 | -0.30% |
| Jun 30, 2016 | -0.19% |
| Mar 31, 2016 | -0.58% |
| Dec 31, 2015 | 1.35% |
| Sep 30, 2015 | -0.06% |
| Jun 30, 2015 | 1.59% |
| Mar 31, 2015 | 0.81% |
| Dec 31, 2014 | 3.86% |
| Sep 30, 2014 | 2.85% |
| Jun 30, 2014 | 4.67% |